These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 26831124

  • 1. Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
    Seravalle G, Brambilla G, Pizzalla DP, Casati A, Riva M, Cuspidi C, Bombelli M, Mancia G, Grassi G.
    J Am Soc Hypertens; 2016 Mar; 10(3):244-51. PubMed ID: 26831124
    [Abstract] [Full Text] [Related]

  • 2. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
    Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC.
    Am J Cardiol; 1997 Feb 15; 79(4):431-5. PubMed ID: 9052345
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC.
    Arzneimittelforschung; 2010 Feb 15; 60(3):124-30. PubMed ID: 20422943
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
    Tsioufis K, Tsioufis C, Dimitriadis K, Mantzouranis E, Mani I, Tousoulis D.
    Curr Med Res Opin; 2016 Oct 15; 32(sup2):35-41. PubMed ID: 27779461
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH, Myers MG, Joyner CD, Toal CB.
    Can J Cardiol; 2002 Dec 15; 18(12):1285-93. PubMed ID: 12518180
    [Abstract] [Full Text] [Related]

  • 6. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension.
    Grassi G, Seravalle G, Turri C, Bolla G, Mancia G.
    Hypertension; 2003 Mar 15; 41(3):558-62. PubMed ID: 12623959
    [Abstract] [Full Text] [Related]

  • 7. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G, Bonaventura A, Romano D, Bianchi L, Fogari E, D'Angelo A, Maffioli P.
    J Clin Pharm Ther; 2014 Jun 15; 39(3):277-85. PubMed ID: 24635387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension].
    Gosteva EV, Vasil'eva LV.
    Kardiologiia; 2015 Jun 15; 55(2):32-6. PubMed ID: 26164986
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG, Pontremoli R.
    J Nephrol; 2011 Jun 15; 24(4):428-37. PubMed ID: 21279953
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group.
    Elliott WJ, Montoro R, Smith D, Leibowitz M, Hwang C, Gradman AH, Schleman M, Klibaner M.
    Am J Hypertens; 1999 Jul 15; 12(7):691-6. PubMed ID: 10411366
    [Abstract] [Full Text] [Related]

  • 17. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA.
    J Hypertens; 2014 Mar 15; 32(3):565-74. PubMed ID: 24378999
    [Abstract] [Full Text] [Related]

  • 18. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C, Flati V, Rossini C, Rufo A, Porteri E, Di Gregorio J, Petroboni B, La Boria E, Donini C, Pasini E, Agabiti Rosei E, Rizzoni D.
    Blood Press; 2014 Dec 15; 23(6):330-8. PubMed ID: 24786779
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C, Stabouli S, Kotsis V.
    Vasc Health Risk Manag; 2016 Dec 15; 12():443-451. PubMed ID: 27895487
    [Abstract] [Full Text] [Related]

  • 20. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
    Fogari R, Zoppi A, Corradi L, Preti P, Malalamani GD, Mugellini A.
    J Hypertens; 2000 Dec 15; 18(12):1871-5. PubMed ID: 11132613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.